{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:55:55Z","timestamp":1790207755352,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.cld.2020.04.005","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T03:46:23Z","timestamp":1590810383000},"page":"421-436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Cholangiocarcinoma"],"prefix":"10.1016","volume":"24","author":[{"given":"Adam P.","family":"Buckholz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Robert S.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2020.04.005_bib1","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","author":"Rizvi","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2020.04.005_bib2","doi-asserted-by":"crossref","DOI":"10.1097\/00000658-199610000-00005","article-title":"Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors","author":"Nakeeb","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.cld.2020.04.005_bib3","article-title":"Burden of digestive diseases in the United States part III: liver, biliary tract, and pancreas","author":"Everhart","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2020.04.005_bib4","doi-asserted-by":"crossref","unstructured":"Glitza IC, Varadhachary GR. Carcinoma of Unknown primary (CUP). In: Cancer Consult: expertise for clinical practice. 2014. https:\/\/doi.org\/10.1002\/9781118589199.ch127.","DOI":"10.1002\/9781118589199.ch127"},{"key":"10.1016\/j.cld.2020.04.005_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","author":"Bridgewater","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2020.04.005_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/MOG.0b013e3282fbf9b3","article-title":"Cholangiocarcinoma: lessons from Thailand","author":"Sripa","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.cld.2020.04.005_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.4815","article-title":"Bile duct cysts in adults","author":"S\u00f6reide","year":"2004","journal-title":"Br J Surg"},{"key":"10.1016\/j.cld.2020.04.005_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/hep.24351","article-title":"Risk factors for cholangiocarcinoma","author":"Tyson","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2020.04.005_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2012.02.022","article-title":"Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma","author":"Palmer","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"02","key":"10.1016\/j.cld.2020.04.005_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2004-828889","article-title":"The epidemiology of cholangiocarcinoma","volume":"24","author":"Shaib","year":"2004","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10.1016\/j.cld.2020.04.005_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/ejso.1999.0660","article-title":"Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management","volume":"25","author":"Rassi","year":"1999","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.cld.2020.04.005_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/j.1572-0241.2000.01685.x","article-title":"The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis","author":"Patel","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2020.04.005_bib13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/1354750X.2014.923048","article-title":"Serum tumor markers in bile duct cancer\u2013a review","volume":"19","author":"Grunnet","year":"2014","journal-title":"Biomarkers"},{"issue":"11","key":"10.1016\/j.cld.2020.04.005_bib14","first-page":"6663","article-title":"Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study","volume":"34","author":"Lumachi","year":"2014","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.cld.2020.04.005_bib15","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/hep.24487","article-title":"Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma","volume":"54","author":"Oseini","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2020.04.005_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2020.04.005_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2013.02.013","article-title":"Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis","author":"Iavarone","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2020.04.005_bib18","doi-asserted-by":"crossref","DOI":"10.1097\/RCT.0b013e3182706562","article-title":"Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging","author":"Kim","year":"2012","journal-title":"J\u00a0Comput Assist Tomogr"},{"key":"10.1016\/j.cld.2020.04.005_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/lt.25052","article-title":"Liver transplantation for intrahepatic cholangiocarcinoma","author":"Lee","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2020.04.005_bib20","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.2016151205","article-title":"Small intrahepatic cholangiocarcinoma and hepatocellular carcinoma in cirrhotic livers may share similar enhancement patterns at multiphase dynamic MR imaging","author":"Huang","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.cld.2020.04.005_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.gassur.2003.10.003","article-title":"Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma","author":"Anderson","year":"2004","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.cld.2020.04.005_bib22","doi-asserted-by":"crossref","DOI":"10.1259\/bjr\/88405305","article-title":"Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis","author":"Ruys","year":"2012","journal-title":"Br J Radiol"},{"key":"10.1016\/j.cld.2020.04.005_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.gie.2016.04.039","article-title":"ERCP tissue sampling","author":"Korc","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cld.2020.04.005_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/j.1572-0241.2004.30281.x","article-title":"A\u00a0comparison of routine cytology and fluorescence in\u00a0situ hybridization for the detection of malignant bile duct strictures","author":"Kipp","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2020.04.005_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.gie.2011.08.040","article-title":"Routine brush cytology and fluorescence in\u00a0situ hybridization for assessment of pancreatobiliary strictures","author":"Smoczynski","year":"2012","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cld.2020.04.005_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/1756283X14564674","article-title":"Triple modality testing by endoscopic retrograde cholangiopancreatography for the diagnosis of cholangiocarcinoma","author":"Nanda","year":"2015","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.cld.2020.04.005_bib27","article-title":"Cholangioscopy biopsies improve detection of cholangiocarcinoma when combined with cytology and FISH, but not in patients with PSC","author":"Kaura","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2020.04.005_bib28","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v19.i6.874","article-title":"Intraductal ultrasound substantiates diagnostics of bile duct strictures of uncertain etiology","author":"Meister","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2020.04.005_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.gie.2010.08.050","article-title":"Role of EUS for preoperative evaluation of cholangiocarcinoma: a large single-center experience","author":"Mohamadnejad","year":"2011","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cld.2020.04.005_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.gie.2007.07.018","article-title":"EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma","author":"Gleeson","year":"2008","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cld.2020.04.005_bib31","doi-asserted-by":"crossref","DOI":"10.4103\/2303-9027.193597","article-title":"Endoscopic retrograde cholangiopancreatography versus endoscopic ultrasound for tissue diagnosis of malignant biliary stricture: systematic review and meta-analysis","author":"De Moura","year":"2018","journal-title":"Endosc Ultrasound"},{"key":"10.1016\/j.cld.2020.04.005_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.1034","article-title":"Diagnostic approach using ERCP-guided transpapillary forceps biopsy or EUS-guided fine-needle aspiration biopsy according to the nature of stricture segment for patients with suspected malignant biliary stricture","author":"Lee","year":"2017","journal-title":"Cancer Med"},{"key":"10.1016\/j.cld.2020.04.005_bib33","article-title":"Impact of preoperative endoscopic ultrasound-guided fine needle aspiration on postoperative recurrence and survival in cholangiocarcinoma patients","author":"Chafic","year":"2013","journal-title":"Endoscopy"},{"key":"10.1016\/j.cld.2020.04.005_bib34","doi-asserted-by":"crossref","DOI":"10.1097\/MOG.0b013e32835005bc","article-title":"Endoscopic ultrasound staging of cholangiocarcinoma","author":"Levy","year":"2012","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.cld.2020.04.005_bib35","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2004.08.006","article-title":"The cholangiopathies: disorders of biliary epithelia","author":"Lazaridis","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2020.04.005_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2020.04.005_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/hep.1840100406","article-title":"Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis","author":"Wiesner","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2020.04.005_bib38","doi-asserted-by":"crossref","DOI":"10.1097\/MOG.0000000000000333","article-title":"The evolution of natural history of primary sclerosing cholangitis","author":"Takakura","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.cld.2020.04.005_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2020.04.005_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","author":"Claessen","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2020.04.005_bib41","doi-asserted-by":"crossref","DOI":"10.1007\/s10620-006-9681-4","article-title":"Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis","author":"Fevery","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2020.04.005_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2016.55","article-title":"Duration of inflammatory bowel disease is associated with increased risk of cholangiocarcinoma in patients with primary sclerosing cholangitis and IBD","author":"Gulamhusein","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2020.04.005_bib43","doi-asserted-by":"crossref","DOI":"10.1097\/MEG.0b013e3283554bbf","article-title":"Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience","author":"Chapman","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2020.04.005_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/cld.567","article-title":"Surveillance for cholangiocarcinoma in patients with primary sclerosing cholangitis: effective and justified?","author":"Razumilava","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2020.04.005_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/hep.24570","article-title":"Cancer surveillance in patients with primary sclerosing cholangitis","author":"Razumilava","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2020.04.005_bib46","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clinre.2018.08.013","article-title":"Recent developments in the research on biomarkers of cholangiocarcinoma in primary sclerosing cholangitis","volume":"43","author":"Wannhoff","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.cld.2020.04.005_bib47","article-title":"Long-term outcomes of positive fluorescence in\u00a0situ hybridization tests in primary sclerosing cholangitis","author":"Bangarulingam","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2020.04.005_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29730","article-title":"Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis","author":"Ali","year":"2018","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2020.04.005_bib49","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2018-317993","article-title":"British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis","volume":"68","author":"Chapman","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.cld.2020.04.005_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2011.156","article-title":"High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis","author":"Eaton","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2020.04.005_bib51","doi-asserted-by":"crossref","DOI":"10.5604\/01.3001.0010.5273","article-title":"Curcumin in hepatobiliary disease: pharmacotherapeutic properties and emerging potential clinical applications","author":"Hu","year":"2017","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cld.2020.04.005_bib52","doi-asserted-by":"crossref","DOI":"10.1080\/00365521.2019.1611917","article-title":"Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study","author":"Eaton","year":"2019","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"10.1016\/j.cld.2020.04.005_bib53","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1245\/s10434-009-0631-1","article-title":"The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival","volume":"16","author":"Choi","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.cld.2020.04.005_bib54","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1072-7515(01)01016-X","article-title":"Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes","volume":"193","author":"Weber","year":"2001","journal-title":"J\u00a0Am Coll Surg"},{"issue":"6","key":"10.1016\/j.cld.2020.04.005_bib55","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","article-title":"Treatment and prognosis for patients with intrahepatic cholangiocarcinoma","volume":"149","author":"Mavros","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.cld.2020.04.005_bib56","doi-asserted-by":"crossref","DOI":"10.1097\/01.sla.0000251366.62632.d3","article-title":"Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution","author":"DeOliveira","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.cld.2020.04.005_bib57","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdw324","article-title":"Biliary cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","author":"Valle","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cld.2020.04.005_bib58","doi-asserted-by":"crossref","DOI":"10.1097\/00000658-199912000-00010","article-title":"Extended resections for hilar cholangiocarcinoma","author":"Neuhaus","year":"1999","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.cld.2020.04.005_bib59","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jamcollsurg.2015.09.005","article-title":"Recurrence rate and pattern of perihilar cholangiocarcinoma after curative intent resection","volume":"221","author":"Groot Koerkamp","year":"2015","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.cld.2020.04.005_bib60","doi-asserted-by":"crossref","DOI":"10.1067\/msy.2002.127555","article-title":"Improved survival in resected biliary malignancies","author":"Nakeeb","year":"2002","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.cld.2020.04.005_bib61","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/SLA.0b013e3182708b57","article-title":"Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections","volume":"258","author":"Nagino","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.cld.2020.04.005_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.10641","article-title":"Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma","author":"Le Roy","year":"2018","journal-title":"Br J Surg"},{"issue":"16","key":"10.1016\/j.cld.2020.04.005_bib63","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis","volume":"30","author":"Horgan","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cld.2020.04.005_bib64","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.18.00050","article-title":"Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (Prodige 12-accord 18-Unicancer GI): a randomized phase III study","author":"Edeline","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cld.2020.04.005_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cld.2020.04.005_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/lt.20512","article-title":"Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience","author":"Ghali","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2020.04.005_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.transproceed.2008.08.053","article-title":"Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: a single-center experience","author":"Sotiropoulos","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cld.2020.04.005_bib68","doi-asserted-by":"crossref","DOI":"10.1159\/000332827","article-title":"The role of liver transplantation for intrahepatic cholangiocarcinoma: a single-center experience","author":"Fu","year":"2011","journal-title":"Eur Surg Res"},{"key":"10.1016\/j.cld.2020.04.005_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamcollsurg.2012.02.022","article-title":"Liver transplantation for hepatocellular carcinoma: long-term results suggest excellent outcomes","author":"Doyle","year":"2012","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.cld.2020.04.005_bib70","doi-asserted-by":"crossref","DOI":"10.1034\/j.1600-6143.2002.20812.x","article-title":"Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma","author":"Sudan","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2020.04.005_bib71","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12\u00a0US centers","author":"Darwish Murad","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2020.04.005_bib72","article-title":"Model for End-Stage Liver Disease (MELD) exception for cholangiocarcinoma or biliary dysplasia","author":"Gores","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2020.04.005_bib73","doi-asserted-by":"crossref","DOI":"10.1002\/hep.28744","article-title":"Liver transplantation for \u201cvery early\u201d intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment","author":"Sapisochin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2020.04.005_bib74","unstructured":"Sapisochin G. Liver transplantation for early intrahepatic cholangiocarcinoma (LT for iCCA). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02878473."},{"key":"10.1016\/j.cld.2020.04.005_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/hep.510270201","article-title":"Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study","author":"Bergquist","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2020.04.005_bib76","article-title":"Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma","author":"Wu","year":"2009","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"10.1016\/j.cld.2020.04.005_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/lt.24095","article-title":"Liver transplantation and Whipple surgery combined with chemoradiotherapy for treatment of hilar cholangiocarcinoma in patients with primary sclerosing cholangitis","author":"Nikeghbalian","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2020.04.005_bib78","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer for the ABC-02 Trial Investigators\u2217","author":"Valle","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2020.04.005_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.29471","article-title":"Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: a large multicenter study by the Association des Gastro-Ent\u00e9rologues Oncologues","author":"Brieau","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.cld.2020.04.005_bib80","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.32463","article-title":"Second-line chemotherapy in advanced biliary cancers: a retrospective, multicenter analysis of outcomes","author":"Lowery","year":"2019","journal-title":"Cancer"},{"issue":"15_suppl","key":"10.1016\/j.cld.2020.04.005_bib81","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1200\/JCO.2019.37.15_suppl.4003","volume":"37","author":"Lamarca","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.cld.2020.04.005_bib82","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/cncr.30571","article-title":"A\u00a0phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma","volume":"123","author":"Goyal","year":"2017","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.cld.2020.04.005_bib83","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrgastro.2011.20","article-title":"Cholangiocarcinoma\u2014controversies and challenges","volume":"8","author":"Patel","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2020.04.005_bib84","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/ajg.2016.512","article-title":"Plastic vs. self-expandable metal stents for palliation in malignant biliary obstruction: a series of meta-analyses","volume":"112","author":"Almadi","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"09","key":"10.1016\/j.cld.2020.04.005_bib85","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1055\/a-0659-9864","article-title":"Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline\u2013updated October 2017","volume":"50","author":"Dumonceau","year":"2018","journal-title":"Endoscopy"},{"issue":"12","key":"10.1016\/j.cld.2020.04.005_bib86","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1007\/s10620-014-3264-6","article-title":"Comparison of metal stenting with radiofrequency ablation versus stenting alone for treating malignant biliary strictures: is there an added benefit?","volume":"59","author":"Sharaiha","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"08","key":"10.1016\/j.cld.2020.04.005_bib87","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1055\/s-0043-124870","article-title":"Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial","volume":"50","author":"Yang","year":"2018","journal-title":"Endoscopy"},{"issue":"7","key":"10.1016\/j.cld.2020.04.005_bib88","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3748\/wjg.v23.i7.1278","article-title":"Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma: a systematic review and meta-analysis","volume":"23","author":"Moole","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.cld.2020.04.005_bib89","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1136\/gutjnl-2011-301748","article-title":"Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update","volume":"61","author":"Khan","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.cld.2020.04.005_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvir.2018.04.001","article-title":"Intrahepatic cholangiocarcinoma treated with transarterial yttrium-90 glass microsphere radioembolization: results of a single institution retrospective study","author":"Gangi","year":"2018","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cld.2020.04.005_bib91","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-009-0777-x","article-title":"Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option","author":"Saxena","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.cld.2020.04.005_bib92","doi-asserted-by":"crossref","DOI":"10.1097\/RLU.0000000000000904","article-title":"Glass microspheres 90Y selective internal radiation therapy and chemotherapy as first-line treatment of intrahepatic cholangiocarcinoma","author":"Edeline","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.cld.2020.04.005_bib93","article-title":"Radioembolization plus chemotherapy for first-line treatment of locally advanced intrahepatic cholangiocarcinoma","author":"Edeline","year":"2019","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.cld.2020.04.005_bib94","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/1745-6215-15-311","article-title":"Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial","volume":"15","author":"Kloeckner","year":"2014","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.cld.2020.04.005_bib95","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1200\/JCO.2015.61.3778","article-title":"Ablative radiotherapy doses lead to a substantial prolongation of survival in patients with inoperable intrahepatic cholangiocarcinoma: a retrospective dose response analysis","volume":"34","author":"Tao","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.cld.2020.04.005_bib96","first-page":"1099","article-title":"Stereotactic body radiotherapy (SBRT) for intrahepatic and hilar cholangiocarcinoma","volume":"6","author":"Mahadevan","year":"2015","journal-title":"J\u00a0Cancer"},{"issue":"1097","key":"10.1016\/j.cld.2020.04.005_bib97","doi-asserted-by":"crossref","first-page":"20180688","DOI":"10.1259\/bjr.20180688","article-title":"Stereotactic body radiation therapy in cholangiocarcinoma: a systematic review","volume":"92","author":"Frakulli","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1016\/j.cld.2020.04.005_bib98","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-016-5101-y","article-title":"Program death 1 immune checkpoint and tumor microenvironment: implications for patients with intrahepatic cholangiocarcinoma","author":"Gani","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"15_suppl","key":"10.1016\/j.cld.2020.04.005_bib99","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1200\/JCO.2019.37.15_suppl.4079","article-title":"Pembrolizumab (PEMBRO) for advanced biliary adenocarcinoma: results from the KEYNOTE-028 (KN028) and KEYNOTE-158 (KN158) basket studies","volume":"37","author":"Bang","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"45","key":"10.1016\/j.cld.2020.04.005_bib100","doi-asserted-by":"crossref","first-page":"e17832","DOI":"10.1097\/MD.0000000000017832","article-title":"Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurrent intrahepatic cholangiocarcinoma with bone metastasis","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine (Baltimore)"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326120300301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326120300301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:55:59Z","timestamp":1761069359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326120300301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1089326120300301"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2020.04.005","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2020.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}